- Having symptom B, bone marrow involvement, extra-nodal lymphoma ≥ 2 positions, elevated blood LDH and BCL2 gene rearrangement adversely affect progression-free survival (p < 0.05); while having symptom B, bone marrow involvement, elevated blood LDH and MYC gene rearrangement adversely affected overall survival (p < 0.05).